# US 2016/0256565 A1 · Composite bioabsorbable barrier membranes with sustained dual drug delivery for tissue engineering and guided tissue regeneration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256565 A1
- Document ID: US20160256565A1
- Status: Published application
- Kind: A1
- Application number: 14/636,139
- Filed: 2015-03-02
- Published: 2016-09-08
- Earliest claimed: 2015-03-02
- Inventors: Manoj Muthukuru
- Web page: https://patentgrep.com/patent/US20160256565A1

## CPC

- A61K 9/167: {with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface (with further drug-free outer coating A61K9/5073)}
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 31/65: Tetracyclines
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/6435: {the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin}
- A61K 47/6927: {the form being a solid microparticle having no hollow or gas-filled cores}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

In this invention, composite polymeric barrier membrane is developed for clinical applications related to guided tissue regeneration and guided bone regeneration. The compositions of this polymeric membrane have conventional mechanical functions of a barrier membrane and will enable space maintenance and stabilization of the healing surgical wound. In addition, this composite polymeric membrane comprise dynamic bioactive components for dual drug delivery that will enable sustained delivery of drugs, growth factors or relevant molecules for promoting wound healing and tissue regeneration.

## Claims

### Claim 1

The invention claimed is a composition for bioabsorbable polymeric composite comprising:
a) a hydrogel polymeric core component;
b) two fibrous polymeric peripheral components; and
c) two bioactive sites.

### Claim 2 (depends on 1)

The polymeric composite of claim 1, wherein the said bioactive sites are crosslinked.

### Claim 3 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites are independent of their crosslinked characteristics.

### Claim 4 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites are drug delivery sites.

### Claim 5 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites can encapsulate distinct molecules or drugs.

### Claim 6 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites can encapsulate identical molecules or drugs.

### Claim 7 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites can independently regulate their rates of drug release.

### Claim 8 (depends on 1)

The polymeric composite of claim 1, wherein the two bioactive sites can encapsulate and deliver organic molecules, inorganic molecules, drugs, antimicrobials agents, anti-inflammatory agents, anti-collagenase agents, growth factors, genes, cells, bioactive molecules or bio-inert molecules that have wound healing and/or growth promoting properties.

### Claim 9 (depends on 1)

The composite of claim 1, wherein one of the bioactive sites is polymeric core component.

### Claim 10 (depends on 1)

The composite of claim 1, wherein one of the bioactive sites in one of the fibrous polymeric peripheral components.

### Claim 11 (depends on 1)

The composite of claim 1, wherein polymeric hydrogel core is composed of microspheres, nanospheres or participles capable of drug delivery.

### Claim 12 (depends on 1)

The composite of claim 1, wherein the two fibrous peripheral components are composed of polymeric collagen.

### Claim 13 (depends on 1)

The composite of claim 1, wherein the said hydrogel component and the fibrous components have distinct mechanical and bioactive characteristics.

### Claim 14 (depends on 1)

The composite of claim 1, wherein the one of the fibrous peripheral component is most extensively crosslinked component among the said components in the composite.

### Claim 15 (depends on 1)

The composite of claim 1, wherein one of the fibrous peripheral components has mechanical properties of a barrier membrane.

### Claim 16 (depends on 1)

The composite of claim 1, wherein the said compositions are fabricated in the form of a composite membrane.

### Claim 17 (depends on 1)

The composite of claim 1, wherein drug release kinetics can be altered when the two bioactive sites encapsulate and deliver a single molecular drug.

### Claim 18 (depends on 1)

The composite of claim 1, wherein additive or synergistic regenerative outcome are achieved when the two bioactive sites encapsulate and deliver distinct drugs.

### Claim 19 (depends on 1)

The composite of claim 1, wherein the compositions are suitable for enhancing wound healing and tissue augmentation when applied at tissue engineering sites.

### Claim 20 (depends on 1)

The composite of claim 1, wherein the compositions are suitable for guided tissue regeneration and guided bone regeneration.
